Company news
Kiniksa Pharmaceuticals International, plc news in 2021
Kiniksa Pharmaceuticals International, plc's news releases, calls and decks from 2021, newest first.
Kiniksa Announces Results from Phase 3 Trial of Mavrilimumab in COVID-19-Related ARDS
December 27, 2021
Kiniksa Pharmaceuticals to Present at Evercore ISI 4th Annual HealthCONx Conference
November 22, 2021
Kiniksa Pharmaceuticals Reports Third Quarter 2021 Financial Results and Recent Portfolio Execution
October 31, 2021
Kiniksa Pharmaceuticals to Report Third Quarter 2021 Financial Results on November 1, 2021
October 28, 2021
Kiniksa Pharmaceuticals to Present at 2021 Cantor Fitzgerald Virtual Global Healthcare Conference
September 20, 2021
Kiniksa Announces Launch of ARCALYST Named Patient Program
August 15, 2021
Kiniksa Reports Second Quarter 2021 Financial Results and Recent Corporate and Portfolio Activity
August 2, 2021
Kiniksa Pharmaceuticals to Present at 2021 Wedbush PacGrow Healthcare Conference
August 1, 2021
Kiniksa Pharmaceuticals to Report Second Quarter 2021 Financial Results on August 3, 2021
July 19, 2021
Kiniksa Outlines Next Steps for the Development of Mavrilimumab
June 7, 2021
Kiniksa Announces Issuance of U.S. Patent for Treatment of Recurrent Pericarditis
June 7, 2021
Kiniksa Pharmaceuticals to Present at Goldman Sachs 42nd Annual Global Healthcare Conference
May 31, 2021
Kiniksa Reports First Quarter 2021 Financial Results and Recent Corporate and Portfolio Activity
May 3, 2021
Kiniksa Announces Positive Final Data from Phase 1 Trial of KPL-404
May 3, 2021
Kiniksa Announces Positive Results for Mavrilimumab Phase 2 Trial in Non-Mechanically Ventilated Severe COVID-19 Patients
April 11, 2021
Kiniksa Announces Commercial Availability of ARCALYST ® (rilonacept) for Recurrent Pericarditis
March 31, 2021
Kiniksa Announces FDA Approval of ARCALYST ® (rilonacept) for Recurrent Pericarditis
March 17, 2021
Kiniksa Launches Patient Registry (RESONANCE) for Recurrent Pericarditis
March 1, 2021
Kiniksa Reports Fourth Quarter and Full-Year 2020 Financial Results and Corporate and Pipeline Activity
February 22, 2021
Kiniksa Highlights Corporate Priorities and Expected 2021 Milestones
January 10, 2021
Kiniksa Pharmaceuticals to Present at 39th Annual J.P. Morgan Healthcare Conference
January 3, 2021
Calls in 2021
Decks in 2021
- Investor Presentation (May 2021)
Investor deck · 120 slides · May 2021